4//SEC Filing
Smith Mark Alan 4
Accession 0001415889-18-000188
CIK 0001411685other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:55 PM ET
Size
5.5 KB
Accession
0001415889-18-000188
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2018-02-02+200,000→ 200,000 totalExercise: $1.16Exp: 2028-02-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001677452
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:55 PM ET
- Size
- 5.5 KB